The more you take in what your body needs and the less you live in ways that deplete its resources, the more you live in balance
Insights from Personify Health's Chief Medical Officer With obesity rates and healthcare costs continuing to rise, GLP-1 medications like Ozempic and Wegovy have captured employers' attention, promising significant weight loss and healthcare savings
Pathological sequelae of long-haul COVID
Draw the intended dose, then check for air bubbles and push any out
Its a tri-agnoist which activates the GLP-1 receptor, the GIP receptor, and the glucagon receptor and looks quite remarkable in clinical trials, showing upwards of 24% body weight loss in patients. The delivery methods of these drugs are also evolving
Future prospective studies are warranted to validate these findings and further investigate the underlying mechanisms